Catadegbrutinib (BGB-16673)
Catadegbrutinib (BGB-16673) (E1993-GRP)
Products
Description
Catadegbrutinib (BGB-16673) is an inhibitor of Bruton’s tyrosine kinase (Btk) and can be used in research for the treatment of autoimmune and inflammatory diseases.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | E1993 |
| Target | BTK |